Mavacamten is Being Developed to Treat the Most Common Inherited Form of Heart Disease, Hypertrophic Cardiomyopathy, for which No Targeted Medical Therapies Exist Twelve-week Treatment with Mavacamten Demonstrated Reductions in…
TARRYTOWN, N.Y. and PARIS, April 26, 2019 /PRNewswire/ — * Praluent is the first PCSK9 inhibitor that has shown a meaningful reduction in death from any cause * Praluent treatment effect was observed in…
On June 27th, 2018, the Centers for Medicare and Medicaid Services (CMS) announced that they are reconsidering the National Coverage Determination (NCD) for transcatheter aortic valve replacement (TAVR). A NCD…
Dear ABC Members and Friends, Pharmaceutical CEOs testified before the Senate last month. Tomorrow, Pharmacy Benefit Managers (PBMs) will discuss drug pricing with the Senate Finance Committee. This committee has…
The Association of Black Cardiologists issued a joint statement along with the Alliance for Aging Research, Heart Valve Voice US, and Mended Hearts in response to the Centers for Medicare and Medicaid…
FOR IMMEDIATE RELEASE Portland, OR, March 22, 2019 — Since opening shop in 2015, the mission statement for Classic Men Barbershop & Lounge is to cater to all people that are looking…
